ImmunityBio says Anktiva plus BCG showed durable survival and bladder preservation at 36 months in BCG-unresponsive bladder ...

Armed with new three-year data demonstrating the benefits of Anktiva in a specific patient subset, ImmunityBio is proving its ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...

US biotech ImmunityBio announced that treatment with Anktiva (nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) demonstrates efficacy at 12 and 36 months, including disease-free ...

As of Monday, December 15, Artiva Biotherapeutics, Inc.’s ARTV share price has surged by 45.08%, which has investors questioning if this is right time to sell.

This paper presents an important advance in genetically encoded voltage imaging of the developing zebrafish spinal cord in vivo, capturing voltage dynamics in neuronal populations, single cells, and ...

Good morning Nigeria. Welcome to the Naija News roundup of top newspaper headlines in Nigeria for today, Wednesday, 17th ...

The ustekinumab (Stelara; Janssen Biotech) biosimilar DMB-3115 (Imuldosa; Accord BioPharma) demonstrated clinical efficacy and safety comparable to the reference product through 52 weeks in a recent ...

ImmunityBio (IBRX) announced treatment with Anktiva plus Bacillus Calmette-Guerin demonstrates efficacy at 12 and 36 months, including ...

Christmas gifts - Eco expert Juliet Kinsman selects her favourite presents that genuinely give back to the planet ...

Scientists created a new protein-based gel that can regenerate damaged tooth enamel. The material mimics a natural process to ...